Extreme elevation of serum growth hormone-binding protein concentrations resulting from a novel heterozygous splice site mutation of the growth hormone receptor gene
To view a copy of this licence, visit About this article Cite this article Xia, Y., Huang, C., Zhong, M
These variables determine whether an individual lands on the faster or slower end of the spectrum
Not everyone will need treatment, and no treatments are guaranteed
These tools can identify which patients are most likely to benefit from GLP-1 therapy, potentially allowing for more targeted coverage criteria that optimize both clinical outcomes and healthcare resources.1,5 PRECISION MEDICINE AND AI INNOVATION The integration of AI in GLP-1 therapy is advancing precision medicine in obesity treatment